HEALTH CATALYST INC (HCAT) Forecast, Price Target & Analyst Ratings

NASDAQ:HCAT • US42225T1079

Current stock price

1.16 USD
-0.01 (-0.85%)
At close:
1.2 USD
+0.04 (+3.45%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HEALTH CATALYST INC (HCAT).

Forecast Snapshot

Consensus Price Target

Price Target
$3.95
+ 240.73% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
$0.04
Revenue Estimate
72.09M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
72.94%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$3.95
Upside
+ 240.73%
From current price of $1.16 to mean target of $3.95, Based on 17 analyst forecasts
Low
$2.78
Median
$3.95
High
$5.25

Price Target Revisions

1 Month
0.00%
3 Months
-1.76%

Price Target Summary

17 Wall Street analysts provided a forecast for the next 12 months for HCAT. The average price target is 3.95 USD. This implies a price increase of 240.73% is expected in the next year compared to the current price of 1.16.
The average price target has been revised downward by 1.76% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

HCAT Current Analyst RatingHCAT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

HCAT Historical Analyst RatingsHCAT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
72.94%
HCAT was analyzed by 17 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about HCAT.
In the previous month the buy percentage consensus was at a similar level.
HCAT was analyzed by 17 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-18Wells FargoDowngrade Overweight -> Equal-Weight
2026-03-13Cantor FitzgeraldMaintains Neutral -> Neutral
2026-03-13Stephens & Co.Maintains Equal-Weight -> Equal-Weight
2026-03-13StifelMaintains Hold -> Hold
2026-03-13Canaccord GenuityMaintains Buy -> Buy
2026-03-13CitigroupMaintains Neutral -> Neutral
2026-01-09CitigroupMaintains Neutral -> Neutral
2025-11-11StifelMaintains Hold -> Hold
2025-11-11Wells FargoMaintains Overweight -> Overweight
2025-11-11CitigroupMaintains Neutral -> Neutral
2025-10-08KeybancMaintains Overweight -> Overweight
2025-10-08Evercore ISI GroupMaintains In-Line -> In-Line
2025-10-07Cantor FitzgeraldReiterate Neutral -> Neutral
2025-09-05BTIGReiterate Neutral -> Neutral
2025-08-29Canaccord GenuityMaintains Buy -> Buy
2025-08-28Evercore ISI GroupMaintains In-Line -> In-Line
2025-08-27Piper SandlerDowngrade Overweight -> Neutral
2025-08-11Wells FargoMaintains Overweight -> Overweight
2025-08-08Cantor FitzgeraldDowngrade Overweight -> Neutral
2025-08-08StifelMaintains Hold -> Hold
2025-08-08CitigroupDowngrade Buy -> Neutral
2025-07-09Evercore ISI GroupMaintains In-Line -> In-Line
2025-05-08StifelMaintains Hold -> Hold
2025-05-08Canaccord GenuityMaintains Buy -> Buy
2025-04-25CitigroupMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
$0.04
Revenue Estimate
72.09M
Revenue Q2Q
-9.22%
EPS Q2Q
328.40%
Number of Analysts
12

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
-0.12%
EPS (1 Month)
0.00%
EPS (3 Months)
-6.79%

Next Earnings Summary

HCAT is expected to report earnings on 5/5/2026. The consensus EPS estimate for the next earnings is 0.04 USD and the consensus revenue estimate is 72.09M USD.
The next earnings revenue estimate has been revised downward by 0.12% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
HCAT revenue by date.HCAT revenue by date.
295.938M
7.15%		306.584M
3.60%		311.136M
1.48%		289.67M
-6.90%		290.8M
0.39%		322.2M
10.80%
EBITDA
YoY % growth
HCAT ebitda by date.HCAT ebitda by date.
-44.735M
48.46%		-14.023M
68.65%		14.396M
202.66%		49.788M
245.85%		56.278M
13.04%		54.214M
-3.67%
EBIT
YoY % growth
HCAT ebit by date.HCAT ebit by date.
-86.958M
35.63%		-55.454M
36.23%		-36.104M
34.89%		-17.827M
50.62%		-10.661M
40.20%		-2.606M
75.55%
Operating Margin
HCAT operating margin by date.HCAT operating margin by date.
-29.38%-18.09%-11.60%-6.15%-3.67%-0.81%
EPS
YoY % growth
HCAT eps by date.HCAT eps by date.
0.15
155.56%		0.28
86.67%		0.19
-32.14%		0.36
91.99%		0.44
20.70%		0.38
-14.29%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		0.04
328.40%		0.09
134.17%		0.09
54.41%		0.10
29.63%		0.10
130.17%		0.11
12.52%		0.10
10.10%		0.12
11.47%
Revenue
Q2Q % growth		72.09M
-9.22%		77.049M
-4.55%		77.097M
1.01%		76.911M
2.99%		78.614M
9.05%		79.997M
3.83%		79.452M
3.05%		78.693M
2.32%
EBITDA
Q2Q % growth		9.46M
848.42%		12.266M
-8.05%		12.608M
-57.92%		12.984M
-72.55%		14.33M
51.48%		14.792M
20.59%		13.844M
9.80%		14.465M
11.41%
EBIT
Q2Q % growth		-5.041M
62.89%		-1.661M
85.76%		-1.218M
84.08%		-1.34M
58.15%		2.579M
151.16%		2.648M
259.46%		3.162M
359.57%		1.941M
244.80%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

HCAT Yearly Revenue VS EstimatesHCAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
HCAT Yearly EPS VS EstimatesHCAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -0.5 -1

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
25.70%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
0.58%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
38.88%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

HEALTH CATALYST INC / HCAT Forecast FAQ

Can you provide the average price target for HEALTH CATALYST INC stock?

17 analysts have analysed HCAT and the average price target is 3.95 USD. This implies a price increase of 240.73% is expected in the next year compared to the current price of 1.16.

Can you provide the upcoming earnings date for HEALTH CATALYST INC?

HEALTH CATALYST INC (HCAT) will report earnings on 2026-05-05.

Can you provide the consensus estimates for HEALTH CATALYST INC next earnings?

The consensus EPS estimate for the next earnings of HEALTH CATALYST INC (HCAT) is 0.04 USD and the consensus revenue estimate is 72.09M USD.

What is the number of analysts for HCAT stock?

The number of analysts covering HEALTH CATALYST INC (HCAT) is 17.